Mohsen Agharazii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohsen Agharazii has a total of 403 co-authors. Here are the top co-authors by number of shared publications:
Catherine Fortier
Department of Kinesiology, CHU de Québec-Université Laval Research Center, Faculty of Medicine, Université Laval, Québec City, QC, Canada
23 shared publicationsRichard Larivière
Research Centre CHU de Québec, Endocrinology and Nephrology Axis, L'Hôtel-Dieu de Québec Hospital, Université Laval, Quebec, QC, Canada
18 shared publicationsFabrice Mac-Way
CHU de Québec Research Center- L'Hôtel-Dieu de Québec Hospital, Québec City, Québec, Canada
17 shared publicationsSimon Desmeules
Service de Néphrologie, CHU de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, 11, Côte du Palais, Quebec, QC, G1R 2J6, Canada
13 shared publicationsKarine Marquis
CHU de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Québec, Quebec, Canada
11 shared publicationsMarie-Pier Desjardins
11 shared publications
Latest Publications
- 3 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- p. e048665
Central Systolic Blood Pressure and Left Ventricular Mass: Findings From the International 24‐Hour Aortic Blood Pressure Consortium
Background: Central systolic blood pressure (cSBP) reflects the pressure experienced by vital organs and may be more closely related to hypertensive cardiac damage than brachial SBP. Twenty‐four–hour ambulatory blood pressure monitoring provides additional insight into cardiovascular load beyond office readings. This study investigated the association of 24‐hour cSBP, measured noninvasively with a validated device, with left ventricular mass index (LVMi) and LV hypertrophy. Methods: We analyzed data from 21 centers worldwide (n=2367; 45.5% women; mean age 49.5 years) participating in the International 24‐Hour Aortic Blood Pressure Consortium. Brachial and central 24‐hour SBPs were recorded using the Mobil‐O‐Graph device, calibrated by either systolic/diastolic (cSBP C1) or mean/diastolic (cSBP C2) pressure; LVMi was derived echocardiographically. BP phenotypes (normotension, isolated diastolic and systolic hypertension, and systolic‐diastolic hypertension) were based on 24‐hour brachial BPs, subdivided by cSBP. Results: LVMi correlated most strongly with 24‐hour cSBP C2 ( P P =0.0045 and <0.001, respectively), without interaction. Discordant classification occurred in 14.4% of participants and was linked to higher LVMi in normotension and lower LVMi in systolic‐diastolic hypertension. Conclusions: Twenty‐four–hour central SBP calibrated with oscillometric mean/diastolic pressure (cSBP C2), is more closely associated with LVMi and LV hypertrophy than brachial SBP. These findings highlight the potential clinical value of incorporating central pressure monitoring into risk assessment and hypertension management.
- 3 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- p. e048665
Central Systolic Blood Pressure and Left Ventricular Mass: Findings From the International 24‐Hour Aortic Blood Pressure Consortium
Background: Central systolic blood pressure (cSBP) reflects the pressure experienced by vital organs and may be more closely related to hypertensive cardiac damage than brachial SBP. Twenty‐four–hour ambulatory blood pressure monitoring provides additional insight into cardiovascular load beyond office readings. This study investigated the association of 24‐hour cSBP, measured noninvasively with a validated device, with left ventricular mass index (LVMi) and LV hypertrophy. Methods: We analyzed data from 21 centers worldwide (n=2367; 45.5% women; mean age 49.5 years) participating in the International 24‐Hour Aortic Blood Pressure Consortium. Brachial and central 24‐hour SBPs were recorded using the Mobil‐O‐Graph device, calibrated by either systolic/diastolic (cSBP C1) or mean/diastolic (cSBP C2) pressure; LVMi was derived echocardiographically. BP phenotypes (normotension, isolated diastolic and systolic hypertension, and systolic‐diastolic hypertension) were based on 24‐hour brachial BPs, subdivided by cSBP. Results: LVMi correlated most strongly with 24‐hour cSBP C2 ( P P =0.0045 and <0.001, respectively), without interaction. Discordant classification occurred in 14.4% of participants and was linked to higher LVMi in normotension and lower LVMi in systolic‐diastolic hypertension. Conclusions: Twenty‐four–hour central SBP calibrated with oscillometric mean/diastolic pressure (cSBP C2), is more closely associated with LVMi and LV hypertrophy than brachial SBP. These findings highlight the potential clinical value of incorporating central pressure monitoring into risk assessment and hypertension management.
- 13 February 2026
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (8) , 1754-1763
Subclinical Primary Aldosteronism and eGFR Decline Over Time
Key Points: This prospective study of 976 adults measured the association between subclinical primary aldosteronism and kidney outcomes. Among a general healthy adult population, subclinical primary aldosteronism was associated with steeper decline in eGFR over time. Primary aldosteronism pathophysiology spans a wide unrecognized continuum that parallels the risk for kidney disease. Background: Primary aldosteronism, an overt form of renin-independent aldosterone production, leads to steeper eGFR decline compared with primary hypertension. Mounting evidence suggests that milder forms of renin-independent aldosterone production (subclinical primary aldosteronism) are highly prevalent; however, the link between subclinical primary aldosteronism and eGFR decline remains unknown. Methods: This prospective cohort study included 976 Canadian adults aged 40–69 years, with predominantly normal BP or mild untreated hypertension, from the randomly sampled, population-based CARTaGENE cohort. Aldosterone and renin concentrations were measured at enrollment (2009–2010). Creatinine and cystatin C were measured at enrollment and 5–7 years postenrollment. Multivariable linear mixed regression models were used to measure the associations of aldosterone, renin, and the aldosterone-to-renin ratio (ARR) with eGFR decline over time. Results: The mean (SD) age of participants was 53 (7) years; 51% were female. Mean BP was 121 (15)/72 (10) mm Hg, and 11% had BP ≥140/90 mm Hg. Mean eGFR CrCysC was 109 (16) ml/min per 1.73 m 2 . At higher ARR levels, there was steeper mean eGFR decline over time (Tertile 1 [ARR, ≤0.49 ng/dl per mU/L]: −1.40 [1.77] ml/min per 1.73 m 2 /yr, Tertile 2 [ARR, 0.50–0.87 ng/dl per mU/L]: −1.48 [1.75] ml/min per 1.73 m 2 /yr, Tertile 3 [ARR, >0.87 ng/dl per mU/L]: −1.57 [1.79] ml/min per 1.73 m 2 /yr; P = 0.01), representing 11% steeper decline in the highest versus lowest ARR tertile. At lower renin levels, there was steeper mean eGFR decline over time (Tertile 1 [renin, ≤9.2 mU/L]: −1.59 [1.80] ml/min per 1.73 m 2 /yr, Tertile 2 [renin, 9.3–15.9 mU/L]: −1.53 [1.77] ml/min per 1.73 m 2 /yr, Tertile 3 [renin, >15.9 mU/L]: −1.33 [1.72] ml/min per 1.73 m 2 /yr; P = 0.04), representing 16% steeper eGFR decline in the lowest versus highest renin tertile. There was no significant association between aldosterone and eGFR change over time ( P = 0.50). All aforementioned associations were independent of BP and were consistent among participants with normal BP in isolation. Conclusions: Independent of BP, elevated ARR and suppressed renin were associated with steeper eGFR decline over time.
- 13 February 2026
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 37 (8) , 1754-1763
Subclinical Primary Aldosteronism and eGFR Decline Over Time
Key Points: This prospective study of 976 adults measured the association between subclinical primary aldosteronism and kidney outcomes. Among a general healthy adult population, subclinical primary aldosteronism was associated with steeper decline in eGFR over time. Primary aldosteronism pathophysiology spans a wide unrecognized continuum that parallels the risk for kidney disease. Background: Primary aldosteronism, an overt form of renin-independent aldosterone production, leads to steeper eGFR decline compared with primary hypertension. Mounting evidence suggests that milder forms of renin-independent aldosterone production (subclinical primary aldosteronism) are highly prevalent; however, the link between subclinical primary aldosteronism and eGFR decline remains unknown. Methods: This prospective cohort study included 976 Canadian adults aged 40–69 years, with predominantly normal BP or mild untreated hypertension, from the randomly sampled, population-based CARTaGENE cohort. Aldosterone and renin concentrations were measured at enrollment (2009–2010). Creatinine and cystatin C were measured at enrollment and 5–7 years postenrollment. Multivariable linear mixed regression models were used to measure the associations of aldosterone, renin, and the aldosterone-to-renin ratio (ARR) with eGFR decline over time. Results: The mean (SD) age of participants was 53 (7) years; 51% were female. Mean BP was 121 (15)/72 (10) mm Hg, and 11% had BP ≥140/90 mm Hg. Mean eGFR CrCysC was 109 (16) ml/min per 1.73 m 2 . At higher ARR levels, there was steeper mean eGFR decline over time (Tertile 1 [ARR, ≤0.49 ng/dl per mU/L]: −1.40 [1.77] ml/min per 1.73 m 2 /yr, Tertile 2 [ARR, 0.50–0.87 ng/dl per mU/L]: −1.48 [1.75] ml/min per 1.73 m 2 /yr, Tertile 3 [ARR, >0.87 ng/dl per mU/L]: −1.57 [1.79] ml/min per 1.73 m 2 /yr; P = 0.01), representing 11% steeper decline in the highest versus lowest ARR tertile. At lower renin levels, there was steeper mean eGFR decline over time (Tertile 1 [renin, ≤9.2 mU/L]: −1.59 [1.80] ml/min per 1.73 m 2 /yr, Tertile 2 [renin, 9.3–15.9 mU/L]: −1.53 [1.77] ml/min per 1.73 m 2 /yr, Tertile 3 [renin, >15.9 mU/L]: −1.33 [1.72] ml/min per 1.73 m 2 /yr; P = 0.04), representing 16% steeper eGFR decline in the lowest versus highest renin tertile. There was no significant association between aldosterone and eGFR change over time ( P = 0.50). All aforementioned associations were independent of BP and were consistent among participants with normal BP in isolation. Conclusions: Independent of BP, elevated ARR and suppressed renin were associated with steeper eGFR decline over time.
- Top Cited Papers
- 30 September 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (13) , 913-923
Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study
BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting evidence suggests that milder forms of renin-independent aldosterone production (subclinical PA) are highly prevalent; however, the link between subclinical PA and MACE remains uncertain. METHODS: This prospective study included 2017 Canadian adults 40 to 69 years of age from the randomly sampled, population-based CARTaGENE cohort (Québec, Canada), in which aldosterone and renin concentrations at enrollment (2009–2010) were measured. Follow-up data were obtained via provincial health care administrative database linkage. MACE outcomes consisted of a composite of myocardial infarction, stroke, hospitalization for heart failure, and cardiovascular death. Multivariable linear and nonlinear Cox regression models measured the associations of concentrations of aldosterone, renin, and the aldosterone-to-renin ratio with MACE. Outcome-derived optimal thresholds for these markers were then determined. RESULTS: The mean (SD) age of participants was 56 (8) years, and 45% were women. Mean blood pressure was 129 (15)/76 (10) mm Hg, with hypertension being present in 27%. Over a median follow-up time of 10.8 years, 57 (3%) MACE outcomes occurred. Lower renin concentration (adjusted hazard ratio [aHR], 2.22 [95% CI, 1.02–4.76]) and higher aldosterone-to-renin ratio (aHR, 2.43 [95% CI, 1.15–5.12]) were associated with a higher risk for MACE, whereas no significant association was found with aldosterone concentration (aHR, 1.57 [95% CI, 0.42–5.90]). Renin concentration exhibited a nonlinear relationship with MACE risk. The outcome-derived optimal thresholds to discriminate a higher MACE risk were renin concentration ≤4.0 ng/L (aHR, 2.12 [95% CI, 1.21–3.72]) and aldosterone-to-renin ratio ≥70 pmol/L per ng/L (aHR, 2.03 [95% CI, 1.09–3.80]). All aforementioned associations were independent of blood pressure. CONCLUSIONS: Independent of blood pressure, the subclinical PA biochemical phenotype is associated with an increased risk of MACE. Future studies are necessary to determine whether early identification and targeted treatment of subclinical PA mitigates this risk.
- 30 September 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (13) , 913-923
Top Cited PapersSubclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study
BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (MACEs). Mounting evidence suggests that milder forms of renin-independent aldosterone production (subclinical PA) are highly prevalent; however, the link between subclinical PA and MACE remains uncertain. METHODS: This prospective study included 2017 Canadian adults 40 to 69 years of age from the randomly sampled, population-based CARTaGENE cohort (Québec, Canada), in which aldosterone and renin concentrations at enrollment (2009–2010) were measured. Follow-up data were obtained via provincial health care administrative database linkage. MACE outcomes consisted of a composite of myocardial infarction, stroke, hospitalization for heart failure, and cardiovascular death. Multivariable linear and nonlinear Cox regression models measured the associations of concentrations of aldosterone, renin, and the aldosterone-to-renin ratio with MACE. Outcome-derived optimal thresholds for these markers were then determined. RESULTS: The mean (SD) age of participants was 56 (8) years, and 45% were women. Mean blood pressure was 129 (15)/76 (10) mm Hg, with hypertension being present in 27%. Over a median follow-up time of 10.8 years, 57 (3%) MACE outcomes occurred. Lower renin concentration (adjusted hazard ratio [aHR], 2.22 [95% CI, 1.02–4.76]) and higher aldosterone-to-renin ratio (aHR, 2.43 [95% CI, 1.15–5.12]) were associated with a higher risk for MACE, whereas no significant association was found with aldosterone concentration (aHR, 1.57 [95% CI, 0.42–5.90]). Renin concentration exhibited a nonlinear relationship with MACE risk. The outcome-derived optimal thresholds to discriminate a higher MACE risk were renin concentration ≤4.0 ng/L (aHR, 2.12 [95% CI, 1.21–3.72]) and aldosterone-to-renin ratio ≥70 pmol/L per ng/L (aHR, 2.03 [95% CI, 1.09–3.80]). All aforementioned associations were independent of blood pressure. CONCLUSIONS: Independent of blood pressure, the subclinical PA biochemical phenotype is associated with an increased risk of MACE. Future studies are necessary to determine whether early identification and targeted treatment of subclinical PA mitigates this risk.
- Top Cited PapersOpen Access
- 17 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (39) , 3905-3918
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study
Background and Aims: Increasing evidence suggests that COVID-19 survivors experience long-term cardiovascular complications possibly through development of vascular damage. The study aimed to investigate whether accelerated vascular ageing occurs after COVID-19 infection, and if so, identify its determinants. Methods: This prospective, multicentric, cohort study, included 34 centres in 16 countries worldwide, in 4 groups of participants—COVID-19-negative controls (ⅰ) and three groups of individuals with recent (6 ± 3 months) exposure to SARS-CoV-2: not hospitalized (ⅱ), hospitalized in general wards (ⅲ), and hospitalized in intensive care units (ⅳ). The main outcome was carotid-femoral pulse wave velocity (PWV), an established biomarker of large artery stiffness. Results: 2390 individuals (age 50 ± 15 years, 49.2% women) were recruited. After adjustment for confounders, all COVID-19-positive groups showed higher PWV (+0.41, +0.37, and +0.40 m/s for groups 2–4, P < .001, P = .001 and P = .003) vs. controls [PWV 7.53 (7.09; 7.97) m/s adjusted mean (95% CI)]. In sex-stratified analyses, PWV differences were significant in women [PWV (+0.55, +0.60, and +1.09 m/s for groups 2–4, P < .001 for all)], but not in men. Among COVID-19 positive women, persistent symptoms were associated with higher PWV, regardless of disease severity and cardiovascular confounders [adjusted PWV 7.52 (95% CI 7.09; 7.96) vs. 7.13 (95% CI 6.67; 7.59) m/s, P < .001]. A stable or improved PWV after 12 months was found in the COVID+ groups, whereas a progression was observed in the COVID− group. Conclusions: COVID-19 is associated with early vascular ageing in the long term, especially in women.
- 17 August 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (39) , 3905-3918
Top Cited PapersOpen AccessAccelerated vascular ageing after COVID-19 infection: the CARTESIAN study
Background and Aims: Increasing evidence suggests that COVID-19 survivors experience long-term cardiovascular complications possibly through development of vascular damage. The study aimed to investigate whether accelerated vascular ageing occurs after COVID-19 infection, and if so, identify its determinants. Methods: This prospective, multicentric, cohort study, included 34 centres in 16 countries worldwide, in 4 groups of participants—COVID-19-negative controls (ⅰ) and three groups of individuals with recent (6 ± 3 months) exposure to SARS-CoV-2: not hospitalized (ⅱ), hospitalized in general wards (ⅲ), and hospitalized in intensive care units (ⅳ). The main outcome was carotid-femoral pulse wave velocity (PWV), an established biomarker of large artery stiffness. Results: 2390 individuals (age 50 ± 15 years, 49.2% women) were recruited. After adjustment for confounders, all COVID-19-positive groups showed higher PWV (+0.41, +0.37, and +0.40 m/s for groups 2–4, P < .001, P = .001 and P = .003) vs. controls [PWV 7.53 (7.09; 7.97) m/s adjusted mean (95% CI)]. In sex-stratified analyses, PWV differences were significant in women [PWV (+0.55, +0.60, and +1.09 m/s for groups 2–4, P < .001 for all)], but not in men. Among COVID-19 positive women, persistent symptoms were associated with higher PWV, regardless of disease severity and cardiovascular confounders [adjusted PWV 7.52 (95% CI 7.09; 7.96) vs. 7.13 (95% CI 6.67; 7.59) m/s, P < .001]. A stable or improved PWV after 12 months was found in the COVID+ groups, whereas a progression was observed in the COVID− group. Conclusions: COVID-19 is associated with early vascular ageing in the long term, especially in women.
- Open Access
- 1 January 2025
- Published by S. Karger AG in Pulse
- Vol. 13 (1) , 62-71
Assessing the Validity of Computerized Algorithms for Determining Pulse Wave Velocity: A Clinical Study
Introduction: Aortic stiffness, assessed through carotid-femoral pulse wave velocity (PWV), has been associated with an increased risk of cardiovascular events and mortality. Measurements of PWV are based on the proper identification of the foot of the pulse waveform by either the maximum of the second-derivative method (as used in Complior) or the intersecting tangents algorithms (as used in SphygmoCor). These approaches can give different results, especially at higher PWV ranges. However, these devices also differ by signal acquisition technology, signal filtering, and quality control algorithms, making the true contribution of analytical algorithms uncertain. The aim of the present study was to identify the differences in pulse transit time (PTT) and PWV calculated by these two algorithms when provided with the same input signal. Methods: In 113 subjects, 346 recordings of 10 s were obtained using the Complior Analyse system (PWVComp-2nd). The pulse waves were imported into MATLAB and filtered (n = 4,102 pairs of pulse waves), where after inspection 3,770 pairs were available for determination of PTT using second-derivative and intersecting tangents algorithms (PTTMat-2nd and PTTMat-IT) and the respective PWVMat-2nd and PWVMat-IT for each pair. Additionally, the same pulse wave recordings were analyzed using the SphygmoCor system in simulation mode, employing the intersecting tangents algorithm (PWVSphyg-IT). Results: The mean beat-by-beat PTTMat-2nd and PTTMat-IT were 54.55 ± 18.55 ms (range 15.00–129.00) and 54.61 ± 18.61 ms (range 15.00–126.00) (p = 0.09), respectively. The mean per participant PWVMat-2nd and PWVMat-IT were 9.67 ± 3.46 m/s and 9.66 ± 3.4 m/s with a mean difference of 0.01 ± 0.32 m/s (p = 0.35). The PWVComp-2nd and PWVSphyg-IT were 9.48 ± 3.25 m/s and 9.59 ± 3.25 m/s with a mean difference of 0.11 ± 0.66 m/s (p = 0.04). Conclusion: The present study shows that the difference between the two algorithms is negligible across a wide range of PTT and hence does not support the need for adjusting PWV according to the algorithm used for determining PTT.
- 1 January 2025
- Published by S. Karger AG in Pulse
- Vol. 13 (1) , 62-71
Open AccessAssessing the Validity of Computerized Algorithms for Determining Pulse Wave Velocity: A Clinical Study
Introduction: Aortic stiffness, assessed through carotid-femoral pulse wave velocity (PWV), has been associated with an increased risk of cardiovascular events and mortality. Measurements of PWV are based on the proper identification of the foot of the pulse waveform by either the maximum of the second-derivative method (as used in Complior) or the intersecting tangents algorithms (as used in SphygmoCor). These approaches can give different results, especially at higher PWV ranges. However, these devices also differ by signal acquisition technology, signal filtering, and quality control algorithms, making the true contribution of analytical algorithms uncertain. The aim of the present study was to identify the differences in pulse transit time (PTT) and PWV calculated by these two algorithms when provided with the same input signal. Methods: In 113 subjects, 346 recordings of 10 s were obtained using the Complior Analyse system (PWVComp-2nd). The pulse waves were imported into MATLAB and filtered (n = 4,102 pairs of pulse waves), where after inspection 3,770 pairs were available for determination of PTT using second-derivative and intersecting tangents algorithms (PTTMat-2nd and PTTMat-IT) and the respective PWVMat-2nd and PWVMat-IT for each pair. Additionally, the same pulse wave recordings were analyzed using the SphygmoCor system in simulation mode, employing the intersecting tangents algorithm (PWVSphyg-IT). Results: The mean beat-by-beat PTTMat-2nd and PTTMat-IT were 54.55 ± 18.55 ms (range 15.00–129.00) and 54.61 ± 18.61 ms (range 15.00–126.00) (p = 0.09), respectively. The mean per participant PWVMat-2nd and PWVMat-IT were 9.67 ± 3.46 m/s and 9.66 ± 3.4 m/s with a mean difference of 0.01 ± 0.32 m/s (p = 0.35). The PWVComp-2nd and PWVSphyg-IT were 9.48 ± 3.25 m/s and 9.59 ± 3.25 m/s with a mean difference of 0.11 ± 0.66 m/s (p = 0.04). Conclusion: The present study shows that the difference between the two algorithms is negligible across a wide range of PTT and hence does not support the need for adjusting PWV according to the algorithm used for determining PTT.
- Open Access
Aortic stiffness after living kidney donation: a systematic review and meta-analysis
Objectives Increased aortic stiffness measured with carotid-femoral pulse wave velocity (cf-PWV) has been associated with adverse cardiovascular outcomes. Some studies have reported increased cf-PWV in living kidney donors after nephrectomy. This review aimed to determine the effects of living kidney donation on cf-PWV, glomerular filtration rate (GFR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and their differences versus non-nephrectomised healthy individuals. Design Systematic review and meta-analysis. Data sources Electronic databases (MEDLINE, EMBASE, Cochrane Central databases, Cochrane Register of Controlled Trials, Cochrane Methodology Register, Health Technology Database, Technologies in Health, EBM Reviews, ProQuest and ‘Grey Matters Light’). Databases were searched from inception to December 2022. Eligibility criteria We searched for studies that measured cf-PWV in living kidney donors before and/or after nephrectomy. Non-nephrectomised healthy individuals included as controls were the comparators. Studies that provided age-adjusted cf-PWV reference values in normotensive healthy individuals were also included. Outcome measures We evaluated the mean differences in cf-PWV, GFR and BP before-and-after nephrectomy and their mean differences versus non-nephrectomised healthy comparators. We also explored differences in yearly adjusted cf-PWV changes between donors and normotensive healthy individuals. Data extraction/synthesis Two independent reviewers extracted data and assessed risk of bias (Risk of Bias tool for non-Randomised studies: ROBINS-I) and quality of evidence (GRADE). Pooled effect estimates were calculated using the inverse variance method and analysed with random effect models. Results Nine interventional (652 donors; 602 controls) and 6 reference studies (6278 individuals) were included. cf-PWV increased at 1-year postdonation (p=0.03) and was on average 0.4 m/s (95% CI 0.07; 0.60) higher than in healthy controls (p=0.01). These differences were non-significant 5 years postnephrectomy (p=0.54). GFR decreased after nephrectomy (pConclusions Aortic stiffness increases independent of BP 1 year after kidney donation, but the long-term effects seem minimal. These findings may impact future consent of prospective living kidney donors. PROSPERO registration number CRD42020185551.
Open AccessAortic stiffness after living kidney donation: a systematic review and meta-analysis
Objectives Increased aortic stiffness measured with carotid-femoral pulse wave velocity (cf-PWV) has been associated with adverse cardiovascular outcomes. Some studies have reported increased cf-PWV in living kidney donors after nephrectomy. This review aimed to determine the effects of living kidney donation on cf-PWV, glomerular filtration rate (GFR), systolic blood pressure (SBP), diastolic blood pressure (DBP) and their differences versus non-nephrectomised healthy individuals. Design Systematic review and meta-analysis. Data sources Electronic databases (MEDLINE, EMBASE, Cochrane Central databases, Cochrane Register of Controlled Trials, Cochrane Methodology Register, Health Technology Database, Technologies in Health, EBM Reviews, ProQuest and ‘Grey Matters Light’). Databases were searched from inception to December 2022. Eligibility criteria We searched for studies that measured cf-PWV in living kidney donors before and/or after nephrectomy. Non-nephrectomised healthy individuals included as controls were the comparators. Studies that provided age-adjusted cf-PWV reference values in normotensive healthy individuals were also included. Outcome measures We evaluated the mean differences in cf-PWV, GFR and BP before-and-after nephrectomy and their mean differences versus non-nephrectomised healthy comparators. We also explored differences in yearly adjusted cf-PWV changes between donors and normotensive healthy individuals. Data extraction/synthesis Two independent reviewers extracted data and assessed risk of bias (Risk of Bias tool for non-Randomised studies: ROBINS-I) and quality of evidence (GRADE). Pooled effect estimates were calculated using the inverse variance method and analysed with random effect models. Results Nine interventional (652 donors; 602 controls) and 6 reference studies (6278 individuals) were included. cf-PWV increased at 1-year postdonation (p=0.03) and was on average 0.4 m/s (95% CI 0.07; 0.60) higher than in healthy controls (p=0.01). These differences were non-significant 5 years postnephrectomy (p=0.54). GFR decreased after nephrectomy (pConclusions Aortic stiffness increases independent of BP 1 year after kidney donation, but the long-term effects seem minimal. These findings may impact future consent of prospective living kidney donors. PROSPERO registration number CRD42020185551.
- 1 December 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (12) , e185-e196
Aortic-Femoral Stiffness Gradient and Cardiovascular Risk in Older Adults
BACKGROUND: The aortic-femoral arterial stiffness gradient, calculated as the ratio of lower-limb pulse-wave velocity (PWV) to central (aortic) PWV, is a promising tool for assessing cardiovascular disease (CVD) risk, but whether it predicts incident CVD is unknown. METHODS: We examined the association of the aortic-femoral arterial stiffness gradient measures carotid-femoral stiffness gradient (femoral-ankle PWV divided by carotid-femoral PWV) and the heart-femoral stiffness gradient (femoral-ankle PWV divided by heart-femoral PWV), as well as PWV, with incident CVD (coronary disease, stroke, and heart failure) and all-cause mortality among 3109 participants of the Atherosclerosis Risk in Communities Study cohort (age, 75±5 years; carotid-femoral PWV, 11.5±3.0 m/s), free of CVD. Cox regression was used to estimate hazard ratios (HR) and 95% CIs. RESULTS: Over a median 7.4-year follow-up, there were 322 cases of incident CVD and 410 deaths. In fully adjusted models, only top quartiles of carotid-femoral stiffness gradient (quartile 4: HR, 1.43 [95% CI, 1.03–1.97]; and quartile 3: HR, 1.49 [95% CI, 1.08–2.05]) and heart-femoral stiffness gradient (quartile 4: HR, 1.77 [95% CI, 1.27–2.48]; and quartile 3: HR, 1.41 [95% CI, 1.00–2.00]) were significantly associated with a greater risk of incident CVD. Only high aortic stiffness in combination with low lower-limb stiffness was significantly associated with incident CVD (HR, 1.46 [95% CI, 1.06–2.02]) compared with the referent low aortic stiffness and high lower-limb stiffness. No PWVs were significantly associated with incident CVD. No exposures were associated with all-cause mortality. CONCLUSIONS: The aortic-femoral arterial stiffness gradient may enhance CVD risk assessment in older adults in whom the predictive capacity of traditional risk factors and PWV are attenuated.
- 1 December 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (12) , e185-e196
Aortic-Femoral Stiffness Gradient and Cardiovascular Risk in Older Adults
BACKGROUND: The aortic-femoral arterial stiffness gradient, calculated as the ratio of lower-limb pulse-wave velocity (PWV) to central (aortic) PWV, is a promising tool for assessing cardiovascular disease (CVD) risk, but whether it predicts incident CVD is unknown. METHODS: We examined the association of the aortic-femoral arterial stiffness gradient measures carotid-femoral stiffness gradient (femoral-ankle PWV divided by carotid-femoral PWV) and the heart-femoral stiffness gradient (femoral-ankle PWV divided by heart-femoral PWV), as well as PWV, with incident CVD (coronary disease, stroke, and heart failure) and all-cause mortality among 3109 participants of the Atherosclerosis Risk in Communities Study cohort (age, 75±5 years; carotid-femoral PWV, 11.5±3.0 m/s), free of CVD. Cox regression was used to estimate hazard ratios (HR) and 95% CIs. RESULTS: Over a median 7.4-year follow-up, there were 322 cases of incident CVD and 410 deaths. In fully adjusted models, only top quartiles of carotid-femoral stiffness gradient (quartile 4: HR, 1.43 [95% CI, 1.03–1.97]; and quartile 3: HR, 1.49 [95% CI, 1.08–2.05]) and heart-femoral stiffness gradient (quartile 4: HR, 1.77 [95% CI, 1.27–2.48]; and quartile 3: HR, 1.41 [95% CI, 1.00–2.00]) were significantly associated with a greater risk of incident CVD. Only high aortic stiffness in combination with low lower-limb stiffness was significantly associated with incident CVD (HR, 1.46 [95% CI, 1.06–2.02]) compared with the referent low aortic stiffness and high lower-limb stiffness. No PWVs were significantly associated with incident CVD. No exposures were associated with all-cause mortality. CONCLUSIONS: The aortic-femoral arterial stiffness gradient may enhance CVD risk assessment in older adults in whom the predictive capacity of traditional risk factors and PWV are attenuated.
- Open Access
- 22 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Impact of arterial system alterations due to amputation on arterial stiffness and hemodynamics: a numerical study
Subjects with amputation of the lower limbs are at increased risk of cardiovascular mortality and morbidity. We hypothesize that amputation-induced alterations in the arterial tree negatively impact arterial biomechanics, blood pressure and flow behavior. These changes may interact with other biological factors, potentially increasing cardiovascular risk. To evaluate this hypothesis regarding the purely mechanical impact of amputation on the arterial tree, we used a simulation computer model including a detailed one-dimensional (1D) arterial network model (143 arterial segments) coupled with a zero-dimensional (0D) model of the left ventricle. Our simulations included five settings of the arterial network: (1) 4-limbs control, (2) unilateral amputee (right lower limb), (3) bilateral amputee (both lower limbs), (4) trilateral amputee (lower-limbs and right upper-limb), and (5) quadrilateral amputee (lower and upper limbs). Analysis of regional stiffness, as calculated by pulse wave velocity (PWV) for large-, medium- and small-sized arteries, showed that, while aortic stiffness did not change with increasing degree of amputation, stiffness of medium and smaller-sized arteries increased with greater amputation severity. Despite a staged decrease in cardiac output, the systolic and diastolic blood pressure values increased, resulting in an increase in both central and peripheral pulse pressures but with an attenuation of pulse pressure amplification. The most significant increase in peak systolic pressure and decrease in peak systolic blood flow was observed at the site of the abdominal aorta. Wave separation analysis indicated no changes in the shape of the forward and backward wave components. However, the results from wave intensity analysis showed that with extended amputation, there was an increase in peak forward wave intensity and a rise in the inverse peak of the backward wave intensity, suggesting potential alterations in cardiac hemodynamic load. In conclusion, this simulation study showed that biomechanical and hemodynamic changes in the arterial network geometry could interact with additional risk factors to increase the cardiovascular risk in patients with amputations.
- 22 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-13
Open AccessImpact of arterial system alterations due to amputation on arterial stiffness and hemodynamics: a numerical study
Subjects with amputation of the lower limbs are at increased risk of cardiovascular mortality and morbidity. We hypothesize that amputation-induced alterations in the arterial tree negatively impact arterial biomechanics, blood pressure and flow behavior. These changes may interact with other biological factors, potentially increasing cardiovascular risk. To evaluate this hypothesis regarding the purely mechanical impact of amputation on the arterial tree, we used a simulation computer model including a detailed one-dimensional (1D) arterial network model (143 arterial segments) coupled with a zero-dimensional (0D) model of the left ventricle. Our simulations included five settings of the arterial network: (1) 4-limbs control, (2) unilateral amputee (right lower limb), (3) bilateral amputee (both lower limbs), (4) trilateral amputee (lower-limbs and right upper-limb), and (5) quadrilateral amputee (lower and upper limbs). Analysis of regional stiffness, as calculated by pulse wave velocity (PWV) for large-, medium- and small-sized arteries, showed that, while aortic stiffness did not change with increasing degree of amputation, stiffness of medium and smaller-sized arteries increased with greater amputation severity. Despite a staged decrease in cardiac output, the systolic and diastolic blood pressure values increased, resulting in an increase in both central and peripheral pulse pressures but with an attenuation of pulse pressure amplification. The most significant increase in peak systolic pressure and decrease in peak systolic blood flow was observed at the site of the abdominal aorta. Wave separation analysis indicated no changes in the shape of the forward and backward wave components. However, the results from wave intensity analysis showed that with extended amputation, there was an increase in peak forward wave intensity and a rise in the inverse peak of the backward wave intensity, suggesting potential alterations in cardiac hemodynamic load. In conclusion, this simulation study showed that biomechanical and hemodynamic changes in the arterial network geometry could interact with additional risk factors to increase the cardiovascular risk in patients with amputations.
- 23 August 2024
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 42 (12) , 2115-2121
Estimated versus measured aortic stiffness: implications of diabetes, chronic kidney disease, sex and height
Background: Aortic stiffness is measured by carotid–femoral pulse wave velocity (PWV), but it can also be estimated (ePWV) based on age and brachial mean arterial pressure (MAP). However, diabetes mellitus and/or chronic kidney disease (DM/CKD) may cause more pronounced damage to the arterial wall, changing the pressure and PWV relationship. Furthermore, sex and height could affect PWV through their relationship to the arterial diameter and path length. The aim of the present study was to quantify the extent to which DM/CKD, sex and height affect the validity of ePWV in predicting PWV. Methods: This cross-sectional study evaluated PWV in adult participants at high risk of aortic stiffness, using Complior and the second derivative transit time algorithm (PWV2nd). PWV2nd was converted into intersecting tangent PWV (PWVITc), and ePWV was calculated using the Reference Values for Arterial Stiffness Collaboration formulas. Results: Among 825 patients (62% males), the mean age was 60 ± 17 years, 34% had diabetes mellitus, 69% had CKD, and 24% did not have DM/CKD. MAP, ePWV, PWV2nd, and PWVITc were, respectively, 96 ± 14 mmHg, 9.8 (8.1–11.8) m/s, 9.5 (7.8–11.9) m/s and 11.3 (8.8–15.9) m/s. There was a significant interaction between DM/CKD, sex, and the predictive value of ePWV. Increasing height lowered the intercept but did not affect the slope of the relationship between estimated and measured PWVs. Conclusion: These findings suggest that the current ePWV equations do not accurately predict PWV in patients with DM/CKD, and that sex and height should also be considered in the future ePWV equations.
- 23 August 2024
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 42 (12) , 2115-2121
Estimated versus measured aortic stiffness: implications of diabetes, chronic kidney disease, sex and height
Background: Aortic stiffness is measured by carotid–femoral pulse wave velocity (PWV), but it can also be estimated (ePWV) based on age and brachial mean arterial pressure (MAP). However, diabetes mellitus and/or chronic kidney disease (DM/CKD) may cause more pronounced damage to the arterial wall, changing the pressure and PWV relationship. Furthermore, sex and height could affect PWV through their relationship to the arterial diameter and path length. The aim of the present study was to quantify the extent to which DM/CKD, sex and height affect the validity of ePWV in predicting PWV. Methods: This cross-sectional study evaluated PWV in adult participants at high risk of aortic stiffness, using Complior and the second derivative transit time algorithm (PWV2nd). PWV2nd was converted into intersecting tangent PWV (PWVITc), and ePWV was calculated using the Reference Values for Arterial Stiffness Collaboration formulas. Results: Among 825 patients (62% males), the mean age was 60 ± 17 years, 34% had diabetes mellitus, 69% had CKD, and 24% did not have DM/CKD. MAP, ePWV, PWV2nd, and PWVITc were, respectively, 96 ± 14 mmHg, 9.8 (8.1–11.8) m/s, 9.5 (7.8–11.9) m/s and 11.3 (8.8–15.9) m/s. There was a significant interaction between DM/CKD, sex, and the predictive value of ePWV. Increasing height lowered the intercept but did not affect the slope of the relationship between estimated and measured PWVs. Conclusion: These findings suggest that the current ePWV equations do not accurately predict PWV in patients with DM/CKD, and that sex and height should also be considered in the future ePWV equations.
- 20 January 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 38 (5) , 430-436
Individual versus integration of multiple components of central blood pressure and aortic stiffness in predicting cardiovascular mortality in end-stage renal diseases
Aortic stiffness, measured by carotid-femoral pulse wave velocity (PWV), is a predictor of cardiovascular (CV) mortality in patients with end-stage renal disease (ESRD). Aortic stiffness increases aortic systolic and pulse pressures (cSBP, cPP) and augmentation index adjusted for a heart rate of 75 beats per minute (AIx@75). In this study, we examined if the integration of multiple components of central blood pressure and aortic stiffness (ICPS) into risk score categories could improve CV mortality prediction in ESRD. In a prospective cohort of 311 patients with ESRD on dialysis who underwent vascular assessment at baseline, 118 CV deaths occurred after a median follow-up of 3.1 years. The relationship between hemodynamic parameters and CV mortality was analyzed through Kaplan–Meier and Cox survival analysis. ICPS risk score from 0 to 5 points were calculated from points given to tertiles, and were regrouped into three risk categories (Average, High, Very-High). A strong association was found between the ICPS risk categories and CV mortality (High risk HR = 2.20, 95% CI: 1.05–4.62, P = 0.036); Very-High risk (HR = 4.44, 95% CI: 2.21–8.92, P < 0.001) as compared to the Average risk group. The Very-High risk category remained associated with CV mortality (HR = 3.55, 95% CI: 1.37–9.21, P = 0.009) after adjustment for traditional CV risk factors as compared to the Average risk group. While higher C-statistics value of ICPS categories (C: 0.627, 95% CI: 0.578–0.676, P = 0.001) was not statistically superior to PWV, cPP or AIx@75, the use of ICPS categories resulted in a continuous net reclassification index of 0.56 (95% CI: 0.07–0.99). In conclusion, integration of multiple components of central blood pressure and aortic stiffness may potentially be useful for better prediction of CV mortality in this cohort.
- 20 January 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 38 (5) , 430-436
Individual versus integration of multiple components of central blood pressure and aortic stiffness in predicting cardiovascular mortality in end-stage renal diseases
Aortic stiffness, measured by carotid-femoral pulse wave velocity (PWV), is a predictor of cardiovascular (CV) mortality in patients with end-stage renal disease (ESRD). Aortic stiffness increases aortic systolic and pulse pressures (cSBP, cPP) and augmentation index adjusted for a heart rate of 75 beats per minute (AIx@75). In this study, we examined if the integration of multiple components of central blood pressure and aortic stiffness (ICPS) into risk score categories could improve CV mortality prediction in ESRD. In a prospective cohort of 311 patients with ESRD on dialysis who underwent vascular assessment at baseline, 118 CV deaths occurred after a median follow-up of 3.1 years. The relationship between hemodynamic parameters and CV mortality was analyzed through Kaplan–Meier and Cox survival analysis. ICPS risk score from 0 to 5 points were calculated from points given to tertiles, and were regrouped into three risk categories (Average, High, Very-High). A strong association was found between the ICPS risk categories and CV mortality (High risk HR = 2.20, 95% CI: 1.05–4.62, P = 0.036); Very-High risk (HR = 4.44, 95% CI: 2.21–8.92, P < 0.001) as compared to the Average risk group. The Very-High risk category remained associated with CV mortality (HR = 3.55, 95% CI: 1.37–9.21, P = 0.009) after adjustment for traditional CV risk factors as compared to the Average risk group. While higher C-statistics value of ICPS categories (C: 0.627, 95% CI: 0.578–0.676, P = 0.001) was not statistically superior to PWV, cPP or AIx@75, the use of ICPS categories resulted in a continuous net reclassification index of 0.56 (95% CI: 0.07–0.99). In conclusion, integration of multiple components of central blood pressure and aortic stiffness may potentially be useful for better prediction of CV mortality in this cohort.